DABIGATRAN ETEXILATE MESYLATE vs PRADAXA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 14, 2026·How we rate

Attribute	DABIGATRAN ETEXILATE MESYLATE	PRADAXA
Rating	70/100	72/100
Pharmacy pays	~$27.04 /30	~$27.04 /30
Type	RX	RX
Active ingredient	DABIGATRAN ETEXILATE MESYLATE	DABIGATRAN ETEXILATE MESYLATE
Manufacturer	Breckenridge	Boehringer Ingelheim
Dosage forms	Capsule	Capsule, Oral pellets
Drug class	Direct Thrombin Inhibitor	Direct Thrombin Inhibitor
Boxed warning	None	Boxed warning
Treats	Pulmonary Embolism, Venous Thrombosis	Pulmonary Embolism, Venous Thrombosis

dabigatran etexilate mesylate pradaxa

Rating

70/100

72/100

Pharmacy pays

~$27.04 /30

Type

Active ingredient

DABIGATRAN ETEXILATE MESYLATE

Manufacturer

Breckenridge

Boehringer Ingelheim

Dosage forms

Capsule

Capsule, Oral pellets

Drug class

Direct Thrombin Inhibitor

Boxed warning

None

Boxed warning

Treats

Pulmonary Embolism, Venous Thrombosis

Frequently asked questions

Which is better-rated, Dabigatran Etexilate Mesylate or Pradaxa?

By our independent rating, Pradaxa scores higher — 3.6 vs 3.5 out of 5 for Dabigatran Etexilate Mesylate. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Dabigatran Etexilate Mesylate or Pradaxa?

Pharmacies pay about the same to acquire either one — roughly $27.04 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Dabigatran Etexilate Mesylate and Pradaxa?

Both Dabigatran Etexilate Mesylate and Pradaxa share the active ingredient Dabigatran Etexilate Mesylate.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.